Concurrent Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $852K | Buy |
1,622
+936
| +136% | +$492K | 0.02% | 648 |
|
|
2025
Q1 | $435K | Buy |
686
+12
| +2% | +$7.61K | 0.01% | 780 |
|
|
2024
Q4 | $480K | Sell |
674
-187
| -22% | -$133K | 0.01% | 669 |
|
|
2024
Q3 | $906K | Buy |
861
+30
| +4% | +$31.6K | 0.03% | 484 |
|
|
2024
Q2 | $874K | Buy |
831
+37
| +5% | +$38.9K | 0.03% | 455 |
|
|
2024
Q1 | $764K | Buy |
794
+437
| +122% | +$421K | 0.03% | 432 |
|
|
2023
Q4 | $313K | Buy |
+357
| New | +$313K | 0.01% | 632 |
|